A Study of SYH2069 Injection in Healthy Participants

NCT07736391 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity
Diabetes

Interventions

DRUG: SYH2069 Injection
DRUG: Placebo

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.